Table of Contents Table of Contents
Previous Page  123 / 812 Next Page
Information
Show Menu
Previous Page 123 / 812 Next Page
Page Background

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348

S119

– the concentration of the CIK (circulating immunnokompleks) was

determined by precipitation with polyethylene glycol.

Patients of the 1st group was administered into the sevpram

10mg/day in combination with galavit (25mg daily); group 2 –

only the standard therapy (ST).

The results of research

As a result of the treatment in the first

group showed an increase of 34.8%) the number of immunoglob-

ulin A, which however does not reach the level of healthy people

and reducing the number of circulating complexes by 13.8%, which

also indicates the normalization of this index. The first group – a

significant improvement of immunological parameters increase of

3 indicators (CD4, CD8, CD4/CD8) and a decrease in the CIK. Anal-

ysis of changes in indicators Hamilton Rating Scale for Depression,

also notes a reduction in the symptoms scores.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.126

EW09

Exercise addiction: Identification and

prevalence in physically active

adolescents and young eating

disordered patients

M. Lichtenstein

1 ,

, R.K. Støving

2

1

Department of Psychology, University of Southern Denmark,

Odense, Denmark

2

Department of Clinical Research, Odense University Hospital,

Odense C, Denmark

Corresponding author.

Introduction

Exercise addiction is characterized by increasing

exercise amounts, withdrawal symptoms and lack of control. Eat-

ing disorders and exercise addiction often appear together, but only

eating disorders are recognized as diagnoses. However, exercise

addiction can exist independently from eating disorders and can

be as harmful as any other addictive behavior.

Objectives

The Exercise Addiction Inventory (EAI) is useful to

identify exercise addiction symptoms in adults and prevalence

rates of 3–10% have been found. But a scale for adolescents does

not yet exist even though behavioral addictions seem to be more

prevalent among young people.

Aims

To develop an instrument for identification of exercise

addiction in adolescents and to estimate the prevalence and nega-

tive consequences.

Methods

We developed a Youth version of the EAI and screened

383 adolescents in sport settings and 69 patients from an eating

disorder department (age range 11–20 years).

Results

The psychometric properties of the scale were good

(Cronbachs alpha 0.71). The prevalence of exercise addiction was

5.5% in adolescents in sport settings and 21.2% in eating disorder

patients. We found a positive linear relationship between EAI-score

and “highweekly exercise amounts” (

r

= 0.4,

P

= 0.00), “the tendency

to exercise in spite of injury” (

r

= 0.4,

P

= 0.00), “feelings of guilt

when not exercising” (

r

= 0.5,

P

= 0.00), “reduced sport performance

related to overtraining” (

r

= 0.2,

P

= 0.00), and “food dominating life”

(

r

= 0.2,

P

= 0.00).

Conclusions

On basis of this study, we recommend the EAI-Y for

identification of exercise addiction in adolescents. Early identifi-

cation is important since it can prevent excessive and obsessive

exercise, injuries, reduced sport performance and eating disorder

pathology.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.127

EW10

PCP analogues in samples of

Barcelona from 2009 to 2015

M. Angelats

1 ,

, L. Galindo

1

, M. Grifell

1

, Á. Palma

1

, L. Martínez

1

,

L. Pujol

1

, M. Ventura

2

, I. Fornís

2

, M. Torrens

3

, M. Farré

4

1

Instituto de Neuropsiquiatría y Adicciones INAD, Parc de Salut Mar,

Psiquiatria, Barcelona, Spain

2

Energy Control, Asociación Bienestar y Desarrollo, Energy Control,

Barcelona, Spain

3

Instituto de Neuropsiquiatría y Adicciones INAD, Parc de Salut Mar,

Institut Hospital del Mar d’Investigacions Mèdiques IMIM, Parc de

Salut Mar, Universitat Autònoma de Barcelona, Psiquiatria,

Barcelona, Spain

4

Institut Hospital del Mar d’Investigacions Mèdiques IMIM, Parc de

Salut Mar, Universitat Autònoma de Barcelona, Servei de

Farmacologia Clínica, Hospital Universitari Germans Trias i Pujol,

IGTP, Farmacología, Barcelona, Spain

Corresponding author.

Introduction

Novel psychoactive substances (NPS) use is progres-

sively increasing year on year. The new analogues of phencyclidine

are frequently sold as legal dissociative anesthetic drug with hal-

lucinogenic and sedative effects, a legal alternative to ketamine,

acting as a high affinity and selective ligand of NMDA receptor

antagonists.

Objectives

To describe the presence of 3- and 4-MeO-PCP in sam-

ples delivered to Energy Control from 2009 to 2015 in Spain.

Methods

A total of 21,198 samples were analyzed from august

2009 to august 2015. Only those samples containing 4-MeO-PCP or

3-MeO-PCP were studied. They were analyzed by Energy Control,

a Spanish harm reduction NGO that offers the possibility of ana-

lyzing the substances that users report. Analysis was done by gas

chromatography–mass spectrometry.

Results

All the samples resulted to be the acquired drug of the

consumer. Three samples were adulterated with substances as tra-

madol, cocaine, acetone among others.

Conclusions

Three and 4-MeO-PCP consumption is not found to

be an emerging issue according to the results of our samples. Even

the potential harmful effects of these dissociative drugs, our indi-

rect indicator seems to show that consumption has not increased. A

more precise monitoring would make a better approach to the real

consumption and the impact of these substances in our society.

Disclosure of interest

The authors declare that they have no com-

peting interest.

Acknowledgement

Supported in part by grants of ISCIII-FEDER

(FIS PI11/0196), and The European Commission (Drug Prevention

and Information Program 2014-16, (JUST/2013/DPIP/AG/4823, EU-

MADNESS project). L. Galindo is a Rio Hortega fellowship (ISCIII;

CM14/00111).

http://dx.doi.org/10.1016/j.eurpsy.2016.01.128

EW11

Methylone consumption

characterized through samples

handled by users

L. Martínez Sadurní

1 ,

, M. Grifell

2

, L. Galindo

2

, I. Ezquiaga

1

,

P. Quintana

3

, M. Ventura

4

, I. Fornís

4

, Á. Palma

2

, M. Angelats

1

,

E. Ribera

1

, M. Torrens

2

, M. Farré

5

1

Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar,

Psychiatry, Barcelona, Spain

2

Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, IMIM,

Universitat Autònoma de Barcelona, Psychiatry, Barcelona, Spain

3

Energy Control, Asociación Bienestar y Desarrollo, Primary care

medicine, Barcelona, Spain

4

Energy Control, Asociación Bienestar y Desarrollo, Energy Control,

Barcelona, Spain